TP53 and oropharynx cancer: In conclusion, our study demonstrated that the combined variant genotypes of p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms individually, and more likely jointly, had a significantly effect on tumor HPV16 status in patients with oropharyngeal cancer, particularly in never-smoker patients.